Investor Relations (IR) Questions: Pozen Inc POZN
Click here to return to the biotech IRQ Index
Answers received: February 2013
1) When is the last time POZN raised cash through an offering (diluted)?
a. POZEN’s last raise of capital was our IPO in October 2000. We have never had a dilutive event.
2) How much cash (not cash equivalents) does POZN have?
a. Net cash reported at the end of Q3 2012 was $92.3 million.
3) What and approximately when is the next known catalyst?
a. We anticipate filing a New Drug Application with the FDA for PA8140/PA32540 in April 2013, and anticipate signing a partnership deal for those drug candidates in 2013.
4) What is POZN's quarterly cash burn?
a. Depending on the level of clinical trial activity, it runs between $15-25 million per quarter.
5) Does POZN have an existing line of credit and if so how much can they draw against it?
a. POZEN does not have a line of credit as we have never needed one. We carry no debt.
1) When is the last time POZN raised cash through an offering (diluted)?
a. POZEN’s last raise of capital was our IPO in October 2000. We have never had a dilutive event.
2) How much cash (not cash equivalents) does POZN have?
a. Net cash reported at the end of Q3 2012 was $92.3 million.
3) What and approximately when is the next known catalyst?
a. We anticipate filing a New Drug Application with the FDA for PA8140/PA32540 in April 2013, and anticipate signing a partnership deal for those drug candidates in 2013.
4) What is POZN's quarterly cash burn?
a. Depending on the level of clinical trial activity, it runs between $15-25 million per quarter.
5) Does POZN have an existing line of credit and if so how much can they draw against it?
a. POZEN does not have a line of credit as we have never needed one. We carry no debt.